- Home
- WORX vs CHRO Comparison
WORX vs CHRO Comparison
Compare WORX & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- CHRO
- Stock Information
- Founded
- WORX N/A
- CHRO 2002
- Country
- WORX United States
- CHRO United States
- Employees
- WORX N/A
- CHRO N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- CHRO
- Sector
- WORX Consumer Discretionary
- CHRO
- Exchange
- WORX Nasdaq
- CHRO Nasdaq
- Market Cap
- WORX 3.4M
- CHRO 3.8M
- IPO Year
- WORX N/A
- CHRO 2024
- Fundamental
- Price
- WORX $1.80
- CHRO $1.90
- Analyst Decision
- WORX
- CHRO Strong Buy
- Analyst Count
- WORX 0
- CHRO 1
- Target Price
- WORX N/A
- CHRO N/A
- AVG Volume (30 Days)
- WORX 57.7K
- CHRO 855.2K
- Earning Date
- WORX 11-14-2024
- CHRO 02-20-2025
- Dividend Yield
- WORX N/A
- CHRO N/A
- EPS Growth
- WORX N/A
- CHRO N/A
- EPS
- WORX N/A
- CHRO N/A
- Revenue
- WORX $3,224,146.00
- CHRO N/A
- Revenue This Year
- WORX N/A
- CHRO N/A
- Revenue Next Year
- WORX N/A
- CHRO N/A
- P/E Ratio
- WORX N/A
- CHRO N/A
- Revenue Growth
- WORX N/A
- CHRO N/A
- 52 Week Low
- WORX $0.75
- CHRO $0.45
- 52 Week High
- WORX $4.44
- CHRO $6.00
- Technical
- Relative Strength Index (RSI)
- WORX 52.47
- CHRO 86.63
- Support Level
- WORX $1.66
- CHRO $0.81
- Resistance Level
- WORX $1.88
- CHRO $1.10
- Average True Range (ATR)
- WORX 0.18
- CHRO 0.26
- MACD
- WORX -0.00
- CHRO 0.08
- Stochastic Oscillator
- WORX 48.96
- CHRO 70.64
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.